BPC
IBB icon

Bearing Point Capital’s iShares Biotechnology ETF IBB Stock Holding History

Bearing Point Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.71M Buy
35,304
+85
+0.2% +$14.6K 0.91% 38
2026
Q1 		$5.95M Sell
35,219
-235
-0.7% -$40.2K 0.93% 42
2025
Q4 		$5.98M Buy
35,454
+1,885
+6% +$306K 0.94% 40
2025
Q3 		$4.85M Buy
33,569
+452
+1% +$61.7K 0.83% 48
2025
Q2 		$4.19M Buy
33,117
+30,617
+1,225% +$3.76M 0.77% 51
2025
Q1 		$320K Buy
+2,500
New +$339K 0.07% 136

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Bearing Point Capital's IBB Position: Q2 2026 in Review

Bearing Point Capital increased its iShares Biotechnology ETF (IBB) stake by 0.24% in Q2 2026, buying an estimated $14.6K and bringing the position to 35,304 shares worth $6.71M. The position accounts for 0.91% of the portfolio, ranked #38.

Bearing Point Capital first reported a position in IBB in Q1 2025 and has held it in 6 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Bearing Point Capital held 35,304 shares of iShares Biotechnology ETF worth $6.71M as of Q2 2026.
  • Bearing Point Capital bought 85 iShares Biotechnology ETF shares in Q2 2026, an estimated $14.6K.
  • iShares Biotechnology ETF made up 0.91% of Bearing Point Capital's portfolio in Q2 2026, its #38 holding.
  • Bearing Point Capital first reported a position in iShares Biotechnology ETF in Q1 2025 and has held it in 6 quarters since.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Bearing Point Capital's 13F filing for Q2 2026, filed 11 Aug 2026.